Cephalalgia

Aims & Scope

Cephalalgia contains original peer reviewed papers on all aspects of headache.

The journal provides an international forum for original research papers, review articles and short communications.

Published monthly on behalf of the International Headache Society.

Readers receive timely cutting edge original articles, editorials, reviews, letters and clinical correspondence on both clinical and basic research.

Subscribers also receive themed Supplements and news on events within the headache community.

Recently published topics include: diagnosis and management of primary and secondary headaches and related syndromes; pathophysiology; mechanisms; pharmacology; epidemiology; imaging; genetics; medico-legal aspects; pharmacoeconomics.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.6
2024	5.00

Journal Rank

Year	Value
2024	2815

Journal Citation Indicator

Year	Value
2024	2082

SJR (SCImago Journal Rank)

Year	Value
2024	1.367

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	148

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

  Citation: 7520

  Authors:

• The International Classification of Headache Disorders, 3rd edition (beta version)

  Citation: 6403

  Authors:

• The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide

  Citation: 1803

  Authors: LJ, K, R, Z, RB, AI, TJ, J-A

• Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study

  Citation: 1210

  Authors: Fulvio, Roberto De, Enrico, Maria, Giuseppe, Pietro

• Preface to the Second Edition

  Citation: 893

  Authors: Jes

• Cgrp May Play A Causative Role in Migraine

  Citation: 874

  Authors: LH, PA, VB, HK, B, J

• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

  Citation: 807

  Authors: HC, DW, SK, CC, RE, RB, SD, MF

• New Appendix Criteria Open for a Broader Concept of Chronic Migraine

  Citation: 756

  Authors: J, M-G, H-C, D, M, PJ, H, MJA, JW, RB, G, F, J, SD, TJ

• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

  Citation: 750

  Authors: SK, DW, CC, RE, SD, RB, HC, MF

• The Triggers or Precipitants of the Acute Migraine Attack

  Citation: 680

  Authors: L

---